Killer fentanyl: Is the fear justified?

Expert Opinion on Drug Safety

Volumn 7, Issue 3, 2008, Pages 213-217

  Fodale, Vincenzo ^a   Mafrica, Federica ^a   Santamaria, Letterio B ^a   Coleman, John J ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b Prescription Drug Research Center   (United States)

Author keywords

Abuse; Anesthesia; Counterfeit drugs; Deaths; Fentanyl; Fentanyl laced heroin; Occupational exposure; Operating rooms; Opioids; Overdose; Pain therapy; Pain treatment; Pharmacogenomics; Public health; Transdermal

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; CYTOCHROME P450 3A5; DIAMORPHINE; FENTANYL; FENTANYL DERIVATIVE; ILLICIT DRUG; MEFENTANYL; METHAMPHETAMINE; NITROUS OXIDE; OPIATE DERIVATIVE; OXYCODONE; STREET DRUG; THIOPENTAL; NARCOTIC ANALGESIC AGENT;

DRUG ABUSE; DRUG COST; DRUG DEPENDENCE; DRUG FATALITY; DRUG INFORMATION; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; EDITORIAL; FEAR; HEALTH PRACTITIONER; HUMAN; INTENSIVE CARE UNIT; INTERNET; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PAIN; PRESCRIPTION; QUALITY CONTROL; SCIENTIFIC LITERATURE; SEIZURE; HEALTH; INTOXICATION; MORTALITY; OPIATE ADDICTION; PUBLIC HEALTH; UNITED STATES;

ANALGESICS, OPIOID; FENTANYL; HUMANS; OPIOID-RELATED DISORDERS; OVERDOSE; PUBLIC HEALTH; UNITED STATES; WORLD HEALTH;

EID: 44949138286     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.7.3.213     Document Type: Editorial

References (10)

1. Boddiger D. Fentanyl-laced street drugs 'kill hundreds'. Lancet 2006;368:569-70
2. Fodale V, Mafrica F, Santamaria LB. Killer fentanyl: a lesson from anesthesiology. Lancet 2006;368:1237-8
3. Treatment Episode Data Set (TEDS): 1994 - 2004. National admissions to substance abuse treatment services. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. DASIS Series: S-33, DHHS Publication No. (SMA) 06-4180, Rockville, MD, 2006. Available from: www.dasis.samhsa.gov/teds04/tedsad2k4web.pdf [Last accessed 4 March 2008]
4. McAuliffe PF, Gold MS, Bajpai L, et al. Secondhand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses 2006;66:874-82
5. Jin M, Gock SB, Jannetto PJ, et al. Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol 2005;29:590-8
6. Safety warnings regarding use of fentanyl transdermal (skin) patches. FDA Public Health Advisory. Washington, DC: FDA/Center for Drug Evaluation and Research, 2005. Available from: www.fda.gov/CDER/drug/ advisery/fentanyl.htm [Last accessed 4 March 2008]
7. Meadows M. Proper use of fentanyl patches. FDA Consumer Magazine; March - April 2006. Available from: http://www.fda.gov/fdac/features/2006/ 206_fentanyl.html [last accessed 4 March 2008]
8. Coleman JJ, Bensinger PB, Gold MS, et al. Can drug design inhibit abuse? J Psychoactive Drugs 2005;37:343-62
9. Annual report 2006; regional highlights, North America. United Nations International Narcotics Control Board, 1 March 2006. Available from: www.incb.org/pdf/e/press/2006/press_release_2006-03-01_3.pdf (Last accessed 4 March 2008]
10. Fodale V, Romeo M, Mafrica F. Fentanyl: are we paying too high a price? J Opioid Manag 2007;3:123-126